www.BIRDFLU-MANUAL.com
PANDEMIC PREPAREDNESS FOR BUSINESSES
PANDEMIC PREPAREDNESS FOR BUSINESSES
SAMPLE BUSINESS IMPACT ANALYSIS
|
High demand items. Secure yours now.
Tamiflu for your staff and families Don’t rely on Government and hospital supplies. There won't be enough. Secure your order here. Relenza - The Tamiflu alternative Evidence is emerging of Tamiflu resistent pandemic flu strains. Hedge your bets and get Relenza here. Alpha Pro Tech N-95 Face Masks Don't get beaten to the post again, stocks won't last. Secure yours here. |
|
FREE Influenza Pandemic Preparedness email eCourse. Get Your Certificate! Join our free pandemic preparedness and planning email eCourse program. Leave your name and email and we’ll take you, one step at a time, through your pandemic preparedness activities, plus give you TWO eBooks on pandemic planning and response for the home. Get a certificate too! To learn more and enroll yourself please click here. |
SAMPLE BUSINESS IMPACT ANALYSIS
This page has been protected from robot content scraping. If you wish to copy content for your personal use please subscribe.
Please note the sample Business Impact Analysis (BIA) shown in this section is designed for business continuity planning in general and is NOT specific to pandemic influenza preparedness. Of course the information gained by conducting a BIA using this example can be used for pandemic preparedness, and indeed should be used in the formation of your pandemic influenza plan.
The purpose of the Business Impact Analysis (BIA) is to identify the effect of many different external and internal impacts upon the various parts of your company in times of crisis. It will show which parts of the organisation will be most affected by an incident and what effect it will have upon the upline and downline operational processes as a whole.
A BIA is typically in the form of a questionnaire which is given to operational managers and/or departmental heads. They fill in the questionnaire themselves and are subsequently interviewed to clarify their answers.
Once all have been interviewed and the answers have been consolidated, the results will give tremendous insight into mission critical/non-critical processes, interdependent processes, back-ups, losses per day of disruption, and much more.
It is a very useful exercise to go through, especially for the respondents, who may have not analysed their jobs in such detail before, even if they have been in that position for many years.
You should use the BIA to establish which business functions/processes are the most critical to the company's survival, and equally, which functions/processes are least critical. It is important to note that the BIA is not a risk analysis or risk assessment. Risks are those 'smaller elements' which threaten processes, and are dealt with separately in our Risk Assessment section.
To see our Risk Assessment section, simply subscribe, then access it from the restricted Bird Flu Manual Online "Contents Page". Subscription is free.
The BIA will allow us to focus efforts on the risks to critical processes whilst allowing us to give less weighting (and human/financial resources) to risks which only effect non-critical processes.
The results of the BIA will ultimately form the backbone of a company's business continuity plan and is very important in the formation of the fundamental structure in which we will proceed. To this end, the questions need to be given due consideration when forming responses.
Additionally whenever possible, respondents should embed or attach charts/graphs/maps to further explain their departmental functions. As a minimum, they should include a freshly drawn department organisation chart and a process map of key processes. These will be identified in the questionnaire.
Respondents should answer the questions as best they can using as little or as much information as they feel is required. If in doubt, use a worst-case scenario to describe disruptions. They will have an opportunity at a later date to meet with the person carrying out the BIA in a one-on-one interview to discuss any questions they may have and to clarify their responses.
Please ensure they limit the scope of their responses to their department only. This will limit the possibility of 'double counting' the function/process ratings that are awarded later. Please note there are no right or wrong answers and no right or wrong way of completing this questionnaire, indeed many of the questions even call for 'gut feelings'.
To create your Business Impact Analysis Questionnaire use the sample generic questions below and add a few of your own as necessary to suit the idiosyncrasies of your industry type. Give respondents a 'box' after each question to place their answers in.
Sample Business Impact Analysis Questionnaire
(A ready made, fully customizable template of this document is available for purchase and download. For details please click here).
Note to respondents: Please read the whole questionnaire at least once before beginning your responses.
SECTION 1: RESPONDENT INFORMATION
1.1 Name: (Your name here:)
1.2 Job Title:
1.3 Department/Division:
1.4 Office Location: (building, floor, room number)
1.5 Experience: (How many years experience have you had with your company and in this industry in general?)
1.6 Skill Sets: (List additional skill sets and working experience you have acquired in your career)
1.7 Disruption Exposure: (Summarise your experiences of disruption in the workplace. What was the cause of the disruption? How long was it before a return to normal? What was the overall short term and long term impact to the business)
1.8 Cross Utilisation: (What other managerial and/or operational roles within your company have you held? Include on long and short term)
1.9 Pandemic Concerns: (If a global pandemic (such as Bird Flu) was to threaten your town/city, what would be your major concerns for your department from a business/operational perspective?)
SECTION 2: KEY DEPARTMENT FUNCTION
2.1 Key Departmental Function: (Describe in summary the primary function performed by your department)
2.2 Key Function Processes: (List and describe the processes used to accomplish this key function. Use process map graphics if possible)
2.3 Key Function Processes Cycle Times: (Quantify the cycle time for each key function process to complete in hours, days, weeks or months)
2.4 Key Function Processes Maximum Outage Tolerance: (List each key function process and state how long you can last without disruption if the process was to fail)
2.5 Key Function Processes Failure Impact Assessment: (List each key function process and give a rating on the operational impact from failure beyond the Maximum Outage Tolerance. Use: 0=no impact, 2=minimal, 4=moderate, 6=moderate heavy, 8=heavy, 10=severe)
2.6 Key Function Process Current Workaround: (List each key function process and state whether a workaround exists and what that workaround is)
SECTION 3: SECONDARY DEPARTMENT FUNCTION(S)
3.1 Secondary Functions: (describe in summary any secondary functions performed by your department)
3.2 Secondary Function Processes: (Describe the processes used to accomplish these secondary functions. Use process map graphics if possible)
3.3 Secondary Function Process Cycle Times: (Quantify the cycle time for each secondary ?function process to complete in hours, days, weeks or months)
3.4 Secondary Function Processes Maximum Outage Tolerance: (List each secondary function process and state how long you can last without disruption if the process was to fail)
3.5 Secondary Function Processes Failure Impact Assessment: (List each secondary function process and give a rating on the operational impact from failure beyond the Maximum Outage Tolerance. Use 0=no impact, 2=minimal, 4=moderate, 6=moderate heavy, 8=heavy, 10=severe)
3.6 Secondary Function Process Current Workaround: (List each secondary function process and state whether a workaround exists and what that workaround is)
SECTION 4: DEPARTMENTAL ASSIGNMENTS
4.1 Deliverables: (Describe the deliverables provided by your department)
4.2 Internal Clients: (List your internal clients)
4.3 External Clients: (List your external clients)
4.4 Compliance/Regulatory Issues: (Describe any regulatory requirements under which your department operates)
4.5 Peak Volumes/Critical Times: (What are your peak volume or critical times and why? Describe daily, weekly, monthly and/or annually)
4.6 Determining what?s lost: (Describe the process if any, you would use to determine what paper/electronic information was lost in any disaster)
4.7 Recovery/Recreation: (Describe the recovery/recreation process you would use for that information)
4.8 Handling Backlog: (Describe the process you would use to handle the backlog and catch up)
4.9 Short Term Planned Changes: (Describe any anticipated changes to the department structure or required systems over the next 24 months)
SECTION 5: INFORMATION TECHNOLOGY
5.1 Operating system used:
5.2 Computer applications used:
5.3 Mainframe/servers located:
5.4 Tech support provided by:
5.5 Manual Backup: (Should the systems be unavailable for an extended period, are there manual backup procedures in place? Are those procedures documented?)
5.6 Vital Records Backup: (Records - all media, hard and soft copies, that are considered essential to the continuation of your departmental services. List below all your current vital records including email and laptop usage)
Vital Data Records
Backed Up: Y or N
If Y - where
If N - action to be taken
How regular is back up performed
SECTION 6: INTER-DEPENDENCIES
6.1 Downline dependencies: (Describe who or what ? internally and externally - is dependent on your department?s function)
6.2 Downline dependencies location: (Where is work sent to from your department and how is it sent? List internal and external client names)
6.3 Downline dependencies failure: (List each downline dependency and describe the impact to each if you are not able to deliver)
6.4 Downline dependencies workaround: (List each downline dependency and describe any existing workarounds for you or the internal/external client)
6.5 Upline dependencies: (Describe who or what function ? internally and externally - your department is dependent on. Where and how is work received from to initiate processes?)
6.6 Upline dependencies failure: (List each upline dependency and describe the impact if any sources are not available?)
6.7 Upline dependencies workaround: (List each upline dependency and describe any existing workarounds)
6.8 Third Party Dependencies: (List any third party dependencies and the impact if they cannot deliver. eg. ad agency unable to provide copy, newswires services down, and describe any existing workarounds)
SECTION 7: DEPARTMENTAL PERSONNEL
7.1 Key Personnel (position) overall responsible for recovery:
7.2 Key Personnel (position) to lead the recovery:
7.3 Deputy Personnel (position) for primary and secondary key personnel:
7.4 Impact if no leadership available: (Describe what would happen if neither primary and secondary and deputies are not available)
7.5 Total Staff: (What is the total number of personnel in your department?)
7.6 Remote Working: (List job functions in your department which can be preformed off premises ie. at home. Include equipment/information requirements)
7.7 Staff Rotation: (Describe any staff rotation scheme or cross utilisation of job functions within your department)
SECTION 8: SUPPLIERS (includes vendors and support)
8.1 Critical Suppliers: (List your department?s critical suppliers, what is supplied and frequency of delivery)
8.2 Critical Supplier Failure: (What is the impact if supply is not available. State maximum tolerances where possible)
8.3 Critical Supplier Failure Workaround: (What workarounds are in place if supply is not available? State maximum tolerances where possible)
8.4 Critical Supplier Contingency Plan: (List suppliers and state if they have a documented contingency plan. Do you have a copy? Has it been tested?)
8.5 Critical Supplier Obligations (State what contractual obligations exist for supply continuity)
SECTION 9: ALTERNATE SITES
9.1 Primary: (Name your primary alternate site location. Include address, space availability, description of infrastructure, communications/ IT access)
9.2 Primary Site Logistics and Special Needs: (Describe physical requirements including security, proximity to upline/downline units, restrictions, access, transport to/from. What set up time is required?)
9.3 Secondary: (Name your secondary alternate site location. Include address, space availability, description of infrastructure, communications/ IT access)
9.4 Secondary Site Logistics and Special Needs: (Describe physical requirements including security, proximity to upline/downline units, restrictions, access, transport to/from. What set up time is required?)
SECTION 10: DEPARTMENT REVENUES & EXPENSES
10.1 Revenues: (List the primary and secondary departmental functions and estimate annual revenues for each one. Put 'nil' if function is not revenue generating)
10.2 Revenues Recapture: (State as a percentage the likelihood of recapturing revenue lost to disruption if the disruption lasts 1 day, 2 days, 3 days etc.)
10.3 Recurring Contractual Revenues: (As a percentage of total departmental revenues what percentage comes from long term recurrent contracts and what comes from daily or short term contracts)
10.4 Material Departmental Costs: (List the Top 5 largest departmental costs eg. staff costs, rental, raw material, paper etc.)
10.5 Mitigating Savings: (What dollar savings would be made in the event of a disruption? Eg. reduction in overtime, or 'rent free period' during building closure. Show the impact if the disruption lasts 1 day, 2 days, 3 days etc.)
SECTION 11: EXPOSURE IDENTIFICATION MATRIX
11.1 Using the accumulated data you have attained by completing the previous sections in this questionnaire, please show your overall 'feel' by populating the following matrix. Determine the exposure that would be incurred by your department should an unplanned interruption in operations occur. In order to establish financial impact, we must estimate loss associated with the loss of the facility and/or automation.
To assist with loss identification, the following impact categories apply:
| Impact Category | Examples: |
| Additional Expense: | Start-up costs, disaster recovery fees, temporary staffing, overtime, purchase/lease/contract external resources (equipment, services, etc.) |
| Assets: | Equipment, furniture, source documentation |
| Customer Service: | Termination or reduction of service level (internal or external clients) |
| Financial Exposure: | Revenue, long & short term contractual income |
| Goodwill: | Public image, shareholder relations, market share |
| Regulatory/Legal: | Fines, penalties, compliance issues, contractual obligations, financial liabilities |
The following number scores have been established to provide firm tangible and intangible exposure categories for cross-company comparison:
Cumulative Dollar-Loss Ranges (Tangible)
| Score: | Dollar Loss Range (US$) |
| 0: | None |
| 1: | Under $10,000 |
| 2: | $10,000 - $25,000 |
| 3: | $25,001 - $50,000 |
| 4: | $50,000 - $100,000 |
| 5: | $100,000 - $250,000 |
| 6: | $250,000 - $500,000 |
| 7: | $500,000 - $1,000,000 |
| 8: | $1,000,000 - $2,500,000 |
| 9: | $2,500,000 - $5,000,000 |
| 10: | $5,000,000 and above |
Customer Service and Goodwill Loss Ranges (Intangible)
| Score: | Effect |
| 0: | None |
| 2: | Minimal |
| 4: | Moderate |
| 6: | Moderately Heavy |
| 8: | Heavy |
| 10: | Severe |
Using the Impact Categories to classify the type of loss incurred and the Loss Ranges (0 through 10), specify your estimated amount of exposure during each time period below:
Click on image to enlarge
Example:
Click on image to enlarge
We encourage you to compile your own Business Impact Analysis Questionnaire and use it to analyse the processes within your business.
You are welcome to make use of (for your own use only) the questions from the example BIA we have provided for you above. These are generic questions which work for almost all businesses, however you may wish to customize the questions to suit your own needs.
Alternatively, download our ready made, fully customizable, Business Impact Analysis Questionnaire Template at our special 50% discount price of only US$24.95 (comes in MS. Word format with a PDF copy).
This discounted price won't last long so we encourage you to take advantage of this offer now.

The 16 page template includes the following Sections:
Introduction and Instructions
Section 1: Respondent Information
Section 2: Key Department Function
Section 3: Secondary Department Function(s)
Section 4: Departmental Assignments
Section 5: Information Technology
Section 6: Inter-Dependencies
Section 7: Departmental Personnel
Section 8: Suppliers (Includes vendors and support)
Section 9: Alternate Sites
Section 10: Department Revenues & Expenses
Section 11: Exposure Identification Matrix
To purchase the template now (even if it's the middle of the night), simply click on the secure PayPal payment button below.
(Please note: Payment will be made to our parent company 'Continuity Business Solutions Ltd.')
Once you have made your payment by credit card or your PayPal account if you have one, you will immediately receive an email with a link to our download page where you can download the template directly to your desktop.
It’s that easy! You’ll be working on your Business Impact Analysis Questionnaire in just a few minutes.
- OR -
BROWSE OUR eSHOP AND TEMPLATES LIBRARY
While you’re there check out some of our other great time saving pandemic preparedness products. And don't forget, all of our products come with a 30-day no questions asked money back guarantee!
For all the tutorials, templates and tools you’ll need to prepare your business for pandemic flu, including conducting your own business impact analysis check out the Pandemic Response Manual for Business Preparedness and Survival.
|
Tamiflu for your staff and families
Don’t rely on Government and hospital supplies. There won't be enough. Get yours here now.
Don’t rely on Government and hospital supplies. There won't be enough. Get yours here now.
More help? Need a complete solution? Something with all the hard work done for you? Something with customisable templates of procedures, presentations, project timelines and tutorials … to hand hold you through it all? Then you’re looking for our Pandemic Response Manual. It has all of this and much, much more. To learn more about it and get some free stuff click here.
|

BE SURE TO CHECK OUT BIRD FLU MANUAL
ONLINE'S OTHER TOPICS BELOW:
(Our Manual gets reviewed and updated regularly so make sure you add this page to your favorites and come back often!)ONLINE'S OTHER TOPICS BELOW:
More help? Need a complete solution? Something with all the hard work done for you? Something with customisable templates of procedures, presentations, project timelines and tutorials … to hand hold you through it all? Then you’re looking for our Pandemic Response Manual. It has all of this and much, much more. To learn more about it and get some free stuff click here.
Latest Bird Flu / Avian Flu News From Medical News Today.
| 06/25/2009 05:00 PM |
| Preclinical Proof-of-Concept Studies Published For Novavax Seasonal Influenza Virus-Like-Particle Vaccine |
|
Novavax, Inc. (Nasdaq: NVAX) announced publication of the preclinical study results that supported the clinical development of the company's investigational VLP vaccine against the H3N2, H1N1 and B influenza strains. The study, which was conducted by scientists from the University of Pittsburgh, Center for Vaccine Research and Novavax, was published in the June 24, 2009 online issue of PLoS ONE.
|
| 06/05/2009 08:00 PM |
| A Closer Look At The I-Con™ - Isolation And Containment For Pandemic Control |
|
American Innovative Research (A.I.R.) cofounders, David Palmer and Judy Piscione, explain how the impact of the avian flu pandemic originally motivated their company's researching a home option of an isolation and containment unit. A.I.R. CEO Palmer states that he and Piscione leveraged decades of success in biomedical research and semiconductor clean-room technology to found American Innovative Research Corp. Palmer defines A.I.R.
|
| 06/05/2009 06:00 PM |
| Animal Production And Health To Be Addressed At FAO/IAEA Symposium |
|
An international symposium to be held in Vienna next week will focus on the use of nuclear technologies to enhance animal nutrition and reproduction strategies and to detect and control animal-origin diseases that can be transmitted to humans, such as swine and avian influenza. Around 500 animal production and health experts from over 100 countries will present up-to-date findings for solving or alleviating factors affecting animal production.
|
| 06/04/2009 04:00 PM |
| Indirect Transmission Can Trigger Influenza Outbreaks In Birds |
|
New data on the persistence of avian influenza viruses in the environment has allowed a team of University of Georgia researchers to create the first model that takes into account both direct and indirect transmission of the viruses among birds. The model, which is detailed in the early online edition of the journal Proceedings of the National Academy of Sciences, has the potential to shed new light on how outbreaks begin in wild bird populations.
|
| 06/02/2009 06:00 PM |
| News From The American Chemical Society, May 27, 2009 |
|
Bird flu virus remains infectious up to 600 days in municipal landfills Amid concerns about a pandemic of swine flu, researchers from Nebraska report for the first time that poultry carcasses infected with another threat - the "bird flu" virus - can remain infectious in municipal landfills for almost 2 years. Their report is scheduled for the June 15 issue of ACS' semi-monthly journal Environmental Science & Technology. Shannon L.
|
| 05/31/2009 04:00 PM |
| Bird Flu Virus Remains Infectious Up To 600 Days In Municipal Landfills |
|
Amid concerns about a pandemic of swine flu, researchers from Nebraska report for the first time that poultry carcasses infected with another threat - the "bird flu" virus - can remain infectious in municipal landfills for almost 2 years. Their report is scheduled for the June 15 issue of ACS' semi-monthly journal Environmental Science & Technology. Shannon L.
|
| 05/25/2009 04:00 PM |
| The Challenges Of Avian Influenza Virus: Mechanism, Epidemiology And Control |
|
The latest special issue of Science in China Series C: Life Sciences focuses on the recent progress in the H5N1-related research field. Early 2009, eight human infection cases of H5N1 highly pathogenic avian influenza (HPAI) virus, with 5 death cases, were reported in China. This again made the world alert on a possible pandemic worldwide, probably caused by avian-origin influenza virus.
|
| 05/25/2009 03:00 PM |
| Tighter Surveillance Of Swine Flu In Pigs Needed Worldwide Says CDC |
|
The US Centers for Disease Control and Prevention (CDC) said that there is a "global need for more systemic surveillance of influenza viruses in pigs", during a press briefing where they explained the findings of a recent study on the genetic and antigenetic properties of the new 2009 H1N1 swine flu virus.
|
| 05/20/2009 10:00 PM |
| In A New Way Of Treating The Flu, Both The H And N Portions Of The Virus Are Targeted |
|
What happens if the next big influenza mutation proves resistant to the available anti-viral drugs? This question is presenting itself right now to scientists and health officials this week at the World Health Assembly in Geneva, Switzerland, as they continue to do battle with H1N1, the so-called swine flu, and prepare for the next iteration of the ever-changing flu virus.
|
| 05/19/2009 09:00 PM |
| New Vaccine Strategy Might Offer Protection Against Pandemic Influenza Strains |
|
A novel vaccine strategy using virus-like particles (VLPs) could provide stronger and longer-lasting influenza vaccines with a significantly shorter development and production time than current ones, allowing public health authorities to react more quickly in the event of a potential pandemic. Ted Ross, Ph.D.
|
| 05/13/2009 08:00 PM |
| News From Burnham Institute For Medical Research, May 2009 |
|
Human monoclonal antibodies effective against bird and seasonal flu viruses Dr. Robert Liddington and colleagues, working with researchers at the Dana-Farber Cancer Institute and the Centers for Disease Control and Prevention, reported the identification of human monoclonal antibodies that neutralize an unprecedented range of influenza A viruses, including avian influenza A (H5N1) virus, previous pandemic influenza viruses and some seasonal influenza viruses.
|
| 05/11/2009 06:00 PM |
| Bird Flu Research Could Help With Swine Flu Vaccine |
|
A study published this week in the Proceedings of the National Academy of Sciences of the United States of America shows that Aflunov®, the Novartis investigational pre-pandemic avian influenza vaccine formulated with Novartis' proprietary MF59® adjuvant, can elicit a broadly cross-reactive immune response covering all known H5N1 antigenic variants, even when that booster dose is administered six years after the initial priming dose.
|
| 05/05/2009 11:00 PM |
| EFPIA Response To The A (H1N1) Novel Influenza Virus |
|
EFPIA is aware and concerned by the current outbreak of a novel influenza, which appears to have originated in Mexico. We note the WHO's decision to raise the level of influenza pandemic alert from the current phase 4 to phase 5. We will continue to monitor the situation closely, working with our colleagues at the International Federation of Pharmaceutical manufacturers and Associations.
|
| 05/02/2009 07:00 PM |
| Novartis Investigational Adjuvanted (MF59) Pre-pandemic Avian Influenza Vaccine Aflunov® Shows Long Lasting, cross-protective Immune Response |
|
A study published this week in the Proceedings of the National Academy of Sciences of the United States of America shows that Aflunov®, the Novartis investigational pre-pandemic avian influenza vaccine formulated with Novartis' proprietary MF59® adjuvant, can elicit a broadly cross-reactive immune response covering all known H5N1 antigenic variants, even when that booster dose is administered six years after the initial priming dose.
|
| 04/30/2009 06:00 PM |
| Avian Flu Research Sheds Light On Swine Flu Outbreak |
|
A new study by University of Maryland researchers suggests that the potential for an avian influenza virus to cause a human flu pandemic is greater than previously thought. Results also illustrate how the current swine flu outbreak likely came about. As of now, avian flu viruses can infect humans who have contact with birds, but these viruses tend not to transmit easily between humans.
|
| 04/29/2009 03:00 PM |
| Is Swine Flu A Worldwide Threat? |
|
After human cases of a new H1N1 swine influenza A virus were first reported in Mexico and then quickly spread around the world, the World Health Organization (WHO) raised its pandemic alert level from phase 3 to phase 4, on April 27. The virus is a fusion of human, pig and avian influenza. There was growing international concern a week ago, after outbreaks of illnesses similar to influenza were reported in Mexico and in other countries.
|
| 04/29/2009 03:00 PM |
| Swine Flu Baffles Experts And Raises More Questions Than Answers |
|
As countries around the world ready themselves for the possibility of a global pandemic in the wake of increasing numbers of confirmed cases of people infected with a new strain of A/H1N1 influenza virus that is being described as swine flu, investigations digging deeper into the history and evidence surrounding the outbreak are coming up with more questions than answers.
|
| 04/28/2009 11:00 PM |
| NanoViricides, Inc. Says Flu-Cide Drug Designed To Destroy All Influenza A Viruses Including Swine And Bird Flu |
|
NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), announced that it is developing FluCide(™), its flagship anti-influenza drug candidate, to work against all influenza types and subtypes. FluCide has been shown to be effective against both common influenza subtype H1N1, as well as two different variants of bird flu subtype H5N1.
|
| 04/28/2009 09:00 PM |
| Pandemic Flu Vaccine 6-Month Time Lag Warns Scientist |
|
New research published April 27 from the University of Leicester and University Hospitals of Leicester NHS Trust warns of a six-month time lag before effective vaccines can be manufactured in the event of a pandemic flu outbreak. By that time, the first wave of pandemic flu may be over before people are vaccinated, says Dr Iain Stephenson, Consultant in Infectious Diseases at the Leicester Royal Infirmary and a Clinical Senior Lecturer at the University of Leicester.
|
| 04/28/2009 06:00 PM |
| Scientist Warns Over Pandemic Flu Vaccine Six-month Time Lag |
|
New research published from the University of Leicester and University Hospitals of Leicester NHS Trust warns of a six-month time lag before effective vaccines can be manufactured in the event of a pandemic flu outbreak. By that time, the first wave of pandemic flu may be over before people are vaccinated, says Dr Iain Stephenson, Consultant in Infectious Diseases at the Leicester Royal Infirmary and a Clinical Senior Lecturer at the University of Leicester.
|











